ABOUT 

Bill Douglass is founder and Managing Principal of Gotham Private Capital. He concurrently runs Gotham Communications, a strategic communications agency that he founded in 2009. Clients have included Index Ventures, Ambry Genetics (sold to Konica Minolta for $1 Billion), Advanced Cell Technology (re-branded as Ocata Therapeutics and sold to Astellas Pharma for $379 Million, as covered in The New York Times), and XO1 Ltd. (sold to Janssen Pharma/Johnson & Johnson), as well as family offices, hedge funds and other private equity and venture capital firms.

From 2022 to 2023, Bill was part of the management team at Hevolution Foundation, a life sciences investor and grant-making organization with an annual budget of up to $1 Billion, where he reported directly to the CEO and sat on the Executive Committee.

A Registered Representative of Stonehaven, LLC, Member FINRA/SIPC, Bill holds the Uniform Securities Agent license (Series 63) and the Private Securities Offerings Representative license (Series 82). He attended Boston University’s College of Communication and earned a BA from the University of Houston. He has spoken at a variety of conferences, including Reuters’ HedgeWorld, IMN Alpha Hedge West, and the Horasis Global Meeting, and his writings have been published in The Economist and elsewhere.

Having traveled to more than 70 countries and worked on five continents, and with deep experience in East Asia and the Middle East, Bill has built an international network of contacts. He lives in Fairfield County, Connecticut, outside New York City, with his wife – a practicing physician – and their two children.